Live
FierceBiotechRoche sticks with €600M diagnostics investment in Germany but warns of future risk10x Genomics Blog10x Genomics (TXG) Expands Capabilities with Proteintech Genomics Acquisition - GuruFocusFierceBiotechCeQur nabs $100M series E to fuel insulin patch commercialization10x Genomics News10x Genomics acquires Proteintech Genomics division - Investing.comPharmaVoiceWith a promising MASH asset, muscle-sparing GLP-1 and new CEO, Rivus gets ready to make its markPharmaVoiceWill obesity drugs save Pfizer from its post-COVID slump?10x Genomics Blog10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group - PR Newswire10x Genomics News10x Genomics Acquires Proteintech Genomics, a Division Within Proteintech Group - TradingViewPromega BlogThe Molecular Blueprint for Virus-Resistant CowpeaFierceBiotechWith ADA in the books, analyst says Lilly is ‘widening its lead’ in the obesity raceFierceBiotechThe new standard for trusted AI in biopharmaEndpoints NewsPost-Hoc Live: How much is everyone in biopharma getting paid?
Curiosis Inc. Apr 20, 2026

Net margin % of Curiosis, Inc. – KRX:494120 - TradingView

Net margin % of Curiosis, Inc. – KRX:494120 - TradingView

Body unavailable. Use the original source.